Insights

Strategic Focus Eagle is a fully integrated pharmaceutical company with R&D, clinical, manufacturing and commercial capabilities, signaling opportunities to partner across the full product lifecycle from development to commercialization in oncology and CNS/metabolic areas.

Product Portfolio Commercialized products include PEMFEXY, RYANODEX, BENDEKA, BELRAPZO, TREAKISYM in Japan, and Byfavo through Acacia Pharma, indicating potential for add-on therapies, regional expansion, and co-promotion partnerships to broaden market access.

Growth Gaps Recent leadership changes and litigation matters suggest a window for BD activity focused on governance-aligned partnerships, risk-managed collaborations, and opportunities to support stability and strategic financing.

Financial Signals Revenue range ($50M–$100M) with funding of $81M implies readiness for strategic investments, licensing deals, or co-development arrangements to scale clinical programs and manufacturing capabilities.

Operational Fit Existing tech stack (Salesforce, SAP, DocuSign, New Relic, among others) and fully integrated operations indicate a good match for enterprise software, compliance, and manufacturing optimization solutions that can streamline pharmacovigilance, supply chain, and regulatory processes.

Similar companies to Eagle Pharmaceuticals, Inc.

Eagle Pharmaceuticals, Inc. Tech Stack

Eagle Pharmaceuticals, Inc. uses 8 technology products and services including Sucuri, Salesforce, SAP, and more. Explore Eagle Pharmaceuticals, Inc.'s tech stack below.

Media & News

Eagle Pharmaceuticals, Inc.'s Email Address Formats

Eagle Pharmaceuticals, Inc. uses at least 3 email formats:
Eagle Pharmaceuticals, Inc. Email FormatsExamplePercentage
FLast@eagleus.comJDoe@eagleus.com
98%
Last.First@eagleus.comDoe.John@eagleus.com
1%
First@eagleus.comJohn@eagleus.com
1%

Frequently Asked Questions

What is Eagle Pharmaceuticals, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Eagle Pharmaceuticals, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Eagle Pharmaceuticals, Inc.'s stock symbol?

Minus sign iconPlus sign icon
Eagle Pharmaceuticals, Inc. is a publicly traded company; the company's stock symbol is EGRX.

What is Eagle Pharmaceuticals, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Eagle Pharmaceuticals, Inc.'s official website is eagleus.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Eagle Pharmaceuticals, Inc. generate?

Minus sign iconPlus sign icon
As of October 2026, Eagle Pharmaceuticals, Inc.'s annual revenue is estimated to be $50M - $100M.

What is Eagle Pharmaceuticals, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Eagle Pharmaceuticals, Inc.'s SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Eagle Pharmaceuticals, Inc. have currently?

Minus sign iconPlus sign icon
As of October 2026, Eagle Pharmaceuticals, Inc. has approximately 99 employees across 3 continents, including North America, Africa and Asia. Key team members include Chief Commercial Officer (cco): B. M., Chief Finance Officer: J. G. and Chief Commercial Officer: S. G. Explore Eagle Pharmaceuticals, Inc.'s employee directory with LeadIQ.

What industry does Eagle Pharmaceuticals, Inc. belong to?

Minus sign iconPlus sign icon
Eagle Pharmaceuticals, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Eagle Pharmaceuticals, Inc. use?

Minus sign iconPlus sign icon
Eagle Pharmaceuticals, Inc.'s tech stack includes Sucuri, Salesforce, SAP, Shopify, Mailgun, DocuSign, New Relic and Piwik PRO Core.

What is Eagle Pharmaceuticals, Inc.'s email format?

Minus sign iconPlus sign icon
Eagle Pharmaceuticals, Inc.'s email format typically follows the pattern of FLast@eagleus.com. Find more Eagle Pharmaceuticals, Inc. email formats with LeadIQ.

How much funding has Eagle Pharmaceuticals, Inc. raised to date?

Minus sign iconPlus sign icon
As of October 2026, Eagle Pharmaceuticals, Inc. has raised $81M in funding. The last funding round occurred on Mar 31, 2025 for $69M.

When was Eagle Pharmaceuticals, Inc. founded?

Minus sign iconPlus sign icon
Eagle Pharmaceuticals, Inc. was founded in 2007.
Eagle Pharmaceuticals, Inc. logo

Eagle Pharmaceuticals, Inc.

Pharmaceutical ManufacturingNew Jersey, United States51-200 Employees

Eagle Pharmaceuticals, Inc. is a mid-sized Westwood, New Jersey-based company with integrated capabilities across research and development, clinical programs, manufacturing, and commercial operations. The company aims to develop innovative medicines intended to bring meaningful improvements to patients' lives. Its marketed portfolio includes PEMFEXY, RYANODEX, BENDEKA, BELRAPZO, and Byfavo and Barhemsys through its subsidiary Acacia Pharma Inc, with TREAKISYM marketed in Japan. Eagle’s oncology and CNS/metabolic critical care pipeline targets underserved therapeutic areas across multiple disease states. A notable recent development is the appointment of Abhinav "Abi" Jain as an independent member of the board in 2025.

Section iconCompany Overview

Phone number
SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
Stock Symbol
EGRX
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2007
Employees
51-200

Section iconFunding & Financials

  • $81M

    Eagle Pharmaceuticals, Inc. has raised a total of $81M of funding over 2 rounds. Their latest funding round was raised on Mar 31, 2025 in the amount of $69M as a Post IPO Debt.

  • $50M - $100M

    Eagle Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $50M - $100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.